Pregnancy and childbirth after treatment with autologous hematopoietic stem cell transplantation for severe systemic sclerosis requiring parenteral nutrition. Ethical issues.
A Tyndall(University Hospital of Basel), Dominique Farge(Hôpital Saint-Louis), B. Carbonne(Princess Grace Hospital Centre), F. Joly, C. Deligny(Centre Hospitalier Universitaire de Martinique)
PubMed
April 6, 2009
Cited by 3
Related Papers
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
|Bone Marrow Transplantation|2015|337